TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nixonnoxin AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
459
|
545
|
491 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
289
|
500
|
351 |
| EBITDA |
241
|
500
|
351 |
| Total assets |
3,009
|
2,858
|
2,727 |
| Current assets |
2,101
|
1,954
|
1,745 |
| Current liabilities |
70
|
82
|
53 |
| Equity capital |
2,789
|
2,637
|
2,539 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
92.7%
|
92.3%
|
93.1% |
| Turnover per employee |
230
|
272
|
246 |
| Profit as a percentage of turnover |
63.0%
|
91.7%
|
71.5% |
| Return on assets (ROA) |
9.6%
|
17.5%
|
12.9% |
| Current ratio |
3001.4%
|
2382.9%
|
3292.5% |
| Return on equity (ROE) |
10.4%
|
19.0%
|
13.8% |
| Change turnover |
-87
|
94
|
-176 |
| Change turnover % |
-16%
|
21%
|
-26% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.